| 000 | 01067 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250517083806.0 | ||
| 264 | 0 | _c20170627 | |
| 008 | 201706s 0 0 eng d | ||
| 022 | _a1744-8360 | ||
| 024 | 7 |
_a10.1586/14737175.2016.1164600 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTolmasov, Michael | |
| 245 | 0 | 0 |
_aPathological and clinical aspects of alpha/beta synuclein in Parkinson's disease and related disorders. _h[electronic resource] |
| 260 |
_bExpert review of neurotherapeutics _c05 2016 |
||
| 300 |
_a505-13 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aParkinson Disease _xmetabolism |
| 650 | 0 | 4 |
_aalpha-Synuclein _xmetabolism |
| 650 | 0 | 4 |
_abeta-Synuclein _xmetabolism |
| 700 | 1 | _aDjaldetti, Ruth | |
| 700 | 1 | _aLev, Nirit | |
| 700 | 1 | _aGilgun-Sherki, Yossi | |
| 773 | 0 |
_tExpert review of neurotherapeutics _gvol. 16 _gno. 5 _gp. 505-13 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1586/14737175.2016.1164600 _zAvailable from publisher's website |
| 999 |
_c25811091 _d25811091 |
||